Pancreatic Cancer Research

ResearcherOsaka City UniversityActive in the last 2 years

Hiroji Shinkawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0164-2414; OpenAlex author ID A5044771753. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.18203↗
  2. [Devising a Surgical Approach Using the Intestinal Derotation Procedure for Locally Advanced Pancreatic Cancer]. Co-author PMID 39948948↗
  3. Pancreaticoduodenectomy with celiac artery resection (PD-CAR) for unresctable locally advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-023-02860-1↗
  4. Prognostic impact of postoperative infection in patients with pancreatic cancer: A multicenter cohort study. Co-author DOI 10.1016/j.surg.2022.09.002↗
  5. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. Co-author DOI 10.21873/anticanres.15718↗
  6. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14234↗
  7. Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Co-author PMID 25911890↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Nishio · 4 shared papers, 2022–2026 · strength 0.79
  2. Ryota Tanaka · 4 shared papers, 2020–2026 · strength 0.71
  3. Takeaki Ishizawa · 3 shared papers, 2023–2026 · strength 0.66
  4. Kenjiro Kimura · 4 shared papers, 2020–2024 · strength 0.59
  5. Kosuke Hatta · 2 shared papers, 2024–2026 · strength 0.48
  6. Shigeaki Kurihara · 2 shared papers, 2024–2026 · strength 0.48
  7. Ryosuke Amano · 3 shared papers, 2020–2023 · strength 0.41
  8. Shoji Kubo · 3 shared papers, 2015–2022 · strength 0.28
  9. Masakazu Yashiro · 2 shared papers, 2020–2022 · strength 0.23
  10. Shimpei Eguchi · 1 shared paper, 2022 · strength 0.13
  11. Kenjiro Okada · 1 shared paper, 2022 · strength 0.12
  12. Taku Aoki · 1 shared paper, 2022 · strength 0.12
  13. Masahiro Iseki · 1 shared paper, 2022 · strength 0.12
  14. Hiroshi Maruyama · 1 shared paper, 2022 · strength 0.12
  15. Masamichi Mizuma · 1 shared paper, 2022 · strength 0.12
  16. Kenichiro Uemura · 1 shared paper, 2022 · strength 0.12
  17. Sadaaki Yamazoe · 1 shared paper, 2020 · strength 0.09
  18. Masaichi Ohira · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.